Ofloxacin eye drops

قطره چشمی افلوکساسین

⚠ Unverified

👁️ Sensory OrgansOphthalmic fluoroquinolone

Market / country: 🇺🇸 USA

Ocuflox (US)

🧮 Dose calculator

Bacterial conjunctivitis (pink eye) · Regimen source: FDA Ofloxacin eye · Dosage and Administration

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ofloxacin eye · Pregnancy

    “Ofloxacin ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
  • 🤱 BreastfeedingDangerous / avoid

    Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Ofloxacin eye · Nursing Mothers

    “Because of the potential for serious adverse reactions from ofloxacin in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Ofloxacin eye · Pediatric Use

    “Safety and effectiveness in infants below the age of one year have not been established.”
  • 👴 Older adultsNo specific problem stated

    Label: no specific difference or dose adjustment stated for older adults. FDA Ofloxacin eye · Geriatric Use

    “No overall differences in safety or effectiveness have been observed between elderly and younger patients.”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav